PPT-Trial Design Evolocumab SC
140 mg Q2W or 420 mg QM Placebo SC Q2W or QM LDLC 70 mg dL or nonHDLC 100 mg dL Followup Q 12 weeks Screening Lipid Stabilization and Placebo Runin High or moderate
Download Presentation
"Trial Design Evolocumab SC" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.